Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2020-05-07
DOI
10.1080/15384047.2020.1750297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles
- (2019) Angelica Ortiz et al. CANCER CELL
- Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
- (2018) Annemarie E.M. Post et al. CLINICAL CANCER RESEARCH
- Tumor inherent interferons: Impact on immune reactivity and immunotherapy
- (2018) Natasha K. Brockwell et al. CYTOKINE
- Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
- (2018) Bogang Wu et al. OncoImmunology
- Interferon-β signal may up-regulate PD-L1 expression through IRF9-dependent and independent pathways in lung cancer cells
- (2018) Yoshie Morimoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma
- (2018) Hailong Ma et al. BRITISH JOURNAL OF CANCER
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- (2017) Natasha K. Brockwell et al. Cancer Immunology Research
- Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms
- (2016) Amy R Peck et al. MODERN PATHOLOGY
- Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
- (2016) Yuliya V. Katlinskaya et al. Cell Reports
- Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer
- (2015) C. N. Johnstone et al. Disease Models & Mechanisms
- Interferons and the Immunogenic Effects of Cancer Therapy
- (2015) Andy J. Minn TRENDS IN IMMUNOLOGY
- DNA-Damage-Induced Type I Interferon Promotes Senescence and Inhibits Stem Cell Function
- (2015) Qiujing Yu et al. Cell Reports
- Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
- (2015) J. Rautela et al. Cancer Immunology Research
- Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
- (2014) Mirjam C. Boelens et al. CELL
- Adipose tissue and adipocytes support tumorigenesis and metastasis
- (2013) Kristin M. Nieman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The Emerging Role of Immunosurveillance in Dictating Metastatic Spread in Breast Cancer
- (2013) C. Y. Slaney et al. CANCER RESEARCH
- Reactivation of p53 as therapeutic intervention for malignant melanoma
- (2013) Aart G. Jochemsen CURRENT OPINION IN ONCOLOGY
- Hope and Fear for Interferon: The Receptor-Centric Outlook on the Future of Interferon Therapy
- (2013) Serge Y. Fuchs JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses
- (2012) S Bhattacharya et al. ONCOGENE
- The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone
- (2012) Clare Y. Slaney et al. OncoImmunology
- Bcr-abl signals to desensitize chronic myeloid leukemia cells to IFN via accelerating the degradation of its receptor
- (2011) S. Bhattacharya et al. BLOOD
- Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis
- (2011) H. Zheng et al. BLOOD
- Inflammatory signaling compromises cell responses to interferon alpha
- (2011) W-C HuangFu et al. ONCOGENE
- Pathogen Recognition Receptor Signaling Accelerates Phosphorylation-Dependent Degradation of IFNAR1
- (2011) Juan Qian et al. PLoS Pathogens
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
- (2008) R. R. Weichselbaum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started